A novel cyclosporine drop formulation demonstrated significant improvement in corneal fluorescein staining (CFS) and in modified Symptom Assessment in Dry Eye (mSANDE) scores in patients with dry eye disease (DED), which was uncontrolled on Restasis (0.05% cyclosporine) therapy.
Auckland’s Toku Inc announced the US Food and Drug Administration has granted Breakthrough Device designation to its CLAiR platform, an investigational, AI-powered technology to assess cardiovascular
Two Lions Eye Institute researchers have won this year’s Nikon Small World Photomicrography Competition with a detailed image of a rodent’s optic nerve head.
A Chinese study found spectacle lenses with highly aspherical lenslets (HAL) reduced or abolished macular choroidal thinning in myopic children, compared to those wearing slightly aspherical lenslets
Research from Australia have linked specific visual field defects to a higher car-crash risk. The University of Western Australia study is the first population-based investigation comparing a
Authors of a new study from the University of Western Australia said the main culprit behind the world’s myopia epidemic is computer screens, not mobile phones or tablets. Senior research fello
Research into keratoconus and eyecare equity in Aotearoa by the University of Auckland’s (UoA’s) Department of Ophthalmology has been bolstered by a significant award and three new fellowships. In S
Qlosi, Orasis Pharmaceuticals’ preservative-free 0.4% pilocarpine formulation, has received US Food and Drug Administration (FDA) approval for the treatment of presbyopia in adults. The company’s ph
A US study has shown optometrist-performed Nd:YAG laser capsulotomies to be safe and effective.
The first fully, immediately sequential, bilateral-cataract surgery (ISBCS) theatre list in the UK was completed at the start of November at the Nightingale Hospital in Exeter by Dr Harry Roberts.
Standing out from more than 1,490 in-person delegates (with a further 240 tuning in online) at this year’s RANZCO Congress in Perth were the 2023 new graduating fellows and many award winners.
US researchers have developed a technique to ‘guide’ blood-derived stem cells to mouse retinas to replace retinal ganglion cells (RGCs) lost to glaucoma. Donor stem cells injected into the eye